New promising Combo therapy in inflammatory bowel diseases refractory to Anti-TNF agents: Cyclosporine plus vedolizumab

Kata Szántó, T. Molnár, Klaudia Farkas

Research output: Letter

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)629
Number of pages1
JournalJournal of Crohn's and Colitis
Issue number5
Publication statusPublished - ápr. 27 2018

ASJC Scopus subject areas

  • Gastroenterology

Cite this